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Abstract
Background: Hemangiopericytoma is a rare mesenchymal neoplasm, accounting for about 1% of
vascular tumors The tumor occurs most commonly in the skin, subcutaneous soft tissues, muscles
of the extremities, retroperitoneum but rarely in the lung, trachea or mediastinum.
Case presentation: A rare case of primary mediastinal hemangiopericytoma is presented. A 72-
year-old woman was treated by complete surgical resection of the tumor. Details of the clinical and
radiographic feature are presented. The patient's postoperative course was uneventful with no
evidence of recurrence 9 months after the operation.
Conclusion: Hemangiopericytoma is an uncommon, potentially malignant tumor originating from
pericytes in the small vessels and surgical radical excision is the treatment of choice, although the
criteria for determining the area of resection have not been established. International literature has
demonstrated that recurrent disease usually occurs within 2 years and therefore a long-term
careful follow-up is required.
Background
Hemangiopericytoma is a rare mesenchymal neoplasm,
accounting for about 1% of vascular tumors [1]. Heman-
giopericytoma is known to be derived from the vascular
pericyte and was first reported by Stout and Murray in
1942 [2]. The tumor occurs most commonly in the skin,
subcutaneous soft tissues, muscles of the extremities, ret-
roperitoneum but rarely in the lung, trachea or mediasti-
num [3]. Herein, a surgical case of primary mediastinal
hemangiopericytoma is presented.
Case presentation
A 72-year-old woman was referred to our institution com-
plaining of dyspnea, cough and chest tightness for the last
two months. Physical examination indicated tachypnea,
orthopnea and use of accessory respiratory muscles. Lab-
oratory studies were essentially within normal limits. A
chest X-ray revealed a homogenous opacity occupying
lower two-thirds of the left hemithorax and causing con-
tralateral shifting of the mediastinum and heart (Figure
1). Thoracentesis was performed in order to palliate respi-
ratory problems. One thousand eight hundred (1800) ml
of serosanguinous fluid were aspirated. Cytologic exami-
nation revealed an exudate with no signs of malignancy.
Culture of the aspirated pleural fluid was also negative. A
computed tomographic scan (CT) of the chest revealed a
large solid tumorous mass measuring 7.3 × 2.3 cm located
in the posterosuperior mediastinum on the left side asso-
ciated with pleural effusion (Figure 2). In order to perform
preoperative staging of the tumor, the patient underwent
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CT scans of brain, upper abdomen, a bone scan and bron-
coscopy. All were normal. The tumor markers alpha-feto-
protein (AFP), carcinoembryonic antigen (CEA), CA 19-9,
neuron-specific enolase (NSE) and squamous cell carci-
noma antigen were within normal limits. The mass
seemed to be resectable and surgical approach was sug-
gested to the patient.
The patient underwent left posterolateral thoracotomy
through 5th intercostal space. During the operation, the
mass appeared to have mediastinal origin and was highly
vascularized. There was no involvement of vital mediasti-
nal structures and the surrounding lung parenchyma was
compressed by the tumor. Six hundred ml of sanguinous
pleural fluid were aspirated. Despite the persistent bleed-
ing during dissection the tumor was resected. The mass
measured 7 × 3 × 2.5 cm and weighed 210 g. Grossly the
resected specimen was a smooth, friable encapsulated
mass with focal hemorrhages. The cut surface was smooth,
elastic and pale brown. Microscopic examination showed
round and spindle cells surrounded by thin-walled,
endothelium-lined vascular channels, giving a "staghorn"
appearance to the vessels as typically seen in hemangi-
opericytoma (Figure 3). The low-mitotic activity and the
absence of clear nuclear pleomorphism were suggestive of
a low-grade malignant tumor. The tumor cells were
immunoreactive only for anti-smooth-muscle-actin pro-
tein (Figure 4).
The postoperative course was uneventful and the patient
was discharged home on postoperative day 9. Postopera-
tive chemoradiotherapy was recommended but the
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patient denied any further treatment. Nine months after
the operation the patient is alive and well without evi-
dence of recurrence of the disease.
Discussion
Hemangiopericytoma is an uncommon, potentially
malignant tumor originating from pericytes in the small
vessels. Intrathoracic hemangiopericytoma usually arises
from pericytes that surround the basement membrane of
capillaries and small venules within the lung parenchyma
[3]. Our case was an intrathoracic mediastinal hemangi-
opericytoma, which is extremely rare. Only a few isolated
case reports are available in the literature [4-7], whereas
the intrapulmonary variety of the same tumor is relatively
more common.
Hemangiopericytoma has no uniform clinical or radio-
graphic features, usually affects older individuals, and
mostly presents as an asymptomatic, non-calcified soli-
tary mass on chest X-ray. These tumors are composed of
closely-packed spindle cells and prominent vascular chan-
nels. The histological differential diagnosis includes many
mesenchymal tumors, such as the solitary fibrous tumor
and the synovial sarcoma [3]. No single clinical or histo-
logical feature including histological type or DNA ploidy
allows prediction of biologic aggressiveness [8]. Malig-
nant hemangiopericytoma is recognized by its increased
mitotic rate, tumor size and foci of hemorrhage and
necrosis [3].
Immunohistochemically, hemangiopericytomas are
known to show a positive response to antibodies against
vimentin and type IV collagen and a negative response to
Preoperative computed tomographic scan demonstrated a tumor mass located in the mediastinum next to descending aorta  and associated with pleural effusion Figure 2
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VIII-related antigen, S-100 protein, neuron specific eno-
lase, carcinoembryonic antigen, desmins, laminin and
cytokeratins [9].
A special consideration concerns the preoperative diagno-
sis. When a mass appears to be radiologically resectable,
many authors perform a thoracotomy without histologi-
cal diagnosis. Previous reports propose an attempt to
obtain a preoperative diagnosis even in tumors that are
clearly resectable if high vascularization is suspected on
imaging techniques [10,11].
Surgical radical excision is the treatment of choice for
hemangiopericytomas, although the criteria for determin-
ing the area of resection have not been established.
Hansen and colleagues stated that it was necessary to con-
sider all hemangiopericytomas as malignant and perform
extended surgery [12]. During the resection, it is impor-
tant to look for invasion of the surrounding lung tissue
and to avoid intrathoracic spread of tumor cells by man-
ual examination. With respect to adjuvant therapy, chem-
otherapy or radiotherapy have been recommended but is
considered to be almost ineffective [3]. On the other hand
Rusch et al., reported that combination therapy or single
therapy with adriamycin was effective against metastases
[13]. Jalal and Jeyasingham reported that preoperative
radiotherapy of large hemangiopericytomas on the chest
wall significantly reduced the vascularity of the tumor and
made complete resection much easier [14]. Some authors
have proposed an innovative approach of treatment,
which includes complete surgical resection along with
intraoperative and postoperative radiotherapy, whereas
others have recommended that radiotherapy may be used
palliatively for local tumor recurrence or superior vena
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cava obstruction [13,15,16]. Morandi et al., recom-
mended preoperative percutaneous embolization of
hypervascular mediastinal tumors, in order to allow a safe
complete removal of the lesion later [17].
The 5-year survival of patients with hemangiopericytoma
originating in any organ has been reported to be 85%,
whereas the survival of patients with a tumor of pulmo-
nary origin is 30–35%. Approximately 50% of hemangi-
opericytomas have been reported to recur within 5 years
[3,12]. It has been demonstrated that recurrent disease
usually occurs within 2 years after initial treatment and
recurrences are commonly found in the thorax, either in
the pulmonary parenchyma or in the pleura. Distant
metastases to liver, brain and bone have also been
reported [12].
Conclusion
Hemangiopericytoma is rare vascular slow-growing tumor
with high local recurrence and the long-term prognosis is
poor because of its propensity to recur. Surgical radical
excision is the treatment of choice despite the fact that the
risk of intraoperative uncontrollable bleeding is high.
Local or distant recurrence is commonly seen and a long-
term careful follow-up is required.
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